Ohio State Navbar

Directory

Kwame Osei, MD


Staff photo

1581 Dodd Dr, 5th Floor McCampbell Hall
Columbus, OH 43210

 

Current OSU Appointments

Professor Emeritus, Endo, Diabetes & Metabolism

Physician, FGP-Endo-Diabetes & Metabolism

 

Certifications

1982 - present Diplomate: American Board of Internal Medicine
1985 - present Diplomate, Subspeciality: Endocrinology & Metabolism: American Board of Internal Medicine
 

Chapters in Books

Osei, K. "The impact of ethnicity and race on hyperinsulinemia, elastic properties of the aorta and cardiovascular diseases inhuman subjects: A new hypothesis?." In In Functional Abnormalities of the Aorta. Edited by Boudoulas H, Toutouzas P, Wooley CF. Armonk,. -. NY: Futura Publications Company, January 1996.

Osei, K. "The impact of ethnicity and race on hyperinsulinemia, elastic properties of the aorta and cardiovascular diseases inhuman subjects: A new hypothesis." In In functional abnormalities of the aorta. Edited by Harisios Boudoulas. -. Austin, TX, US|USA: Futura Publications Company, January 1996.

 

Clinical Services

07/01/1984 Attending (CarePoint East (Effective July 2011), Internal Medicine/Endocrinology)
07/01/1995 Attending (UHE, Inpatient Consults)

Editorial Activities

2008 - present Endocrine Today
2009 - present Journal of Clinical Endocrinology and Metabolism
 

Honors

0 - 1998 Pfizer visiting Professorship. DC General Hospital, Affiliate of.
0 - 1998 Pfizer Visiting Professor. Howard University Medical Center, Washington, DC, United States.
0 - 2000 Mercy Endowed Visiting Professor.
2005 Distinguished Internist of the Year. Internal Medicine Section.
2011 Business First's Health Care Hereos 2011. Columbus Business First.
2011 Business First's Health Care Hereos. Columbus Business First Journal.
2011 Shining Star Award. Ohio State University Family Medicine.
 

Journal Articles

Gaillard, T, Osei K, Schuster D. Green Patricia, Bossetti B. "Do Sociodemographics and Economic Status Predict Risks for Type II Diabetes in African Americans?." The Diabetes Educators. Vol. 23, no. 3. (June 1997.): 294-300.

Gaillard, T, Osei K, Schuster D. Green Patricia, Bossetti B,. "The impact of socioeconomic status on the risk factors for type 2 diabetes and cardiovascular diseases in high risk African Americans: Implications for Syndrome X.." Diabetes Care. Vol. 20, no. 5. (May 1997.): 745-752.

Osei K. "History of gestational diabetes leads to distinct metabolic alterations nondiabetic African Americans with parental history of type 2 diabetes." Diabetes Care. Vol. 21, no. 8. (August 1998.): 1250-1257.

Gaillard, T, Osei K, Schuster D, Green Patricia, Bossetti B. "Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus.." Ethnicity and Disease. Vol. 3, no. 8. (January 1998.): 319-330.

Amoah AGB, Owusu SK, Saunders JT,Fang WI. Barret E. Woode MKA. Osei K. "Facilities and resources for diabetes care at regional health facilities in southern Ghana." Diabetes Research and Clinical Practice. Vol. 42, no. 2. (November 1998.): 123-130.

SCHUSTER, D. KIEN, C; OSEI, K. "Differential Impact of Obesity on Glucose Metabolism in Black and White American Adolescents." American Journal of the Medical Sciences. Vol. 316, no. 6. (December 1998.): 361-367.

Kallaras K, Sparks EA, Schuster DP, Osei K, Wolley CF, Boudoulas H. "Integration of Circulatory Mechanisms: Left ventricular mass, aortic function and left ventricular performance." Journal of Noninvasive Cardiology. no. 3. (January 1999.): 177-184.

Osei K, Gaillard T, Schuster D. "Cardiovascular risk factors in African Americans with varying degrees of glucose intolerance: Comparison of New American Diabetes Association vs.Old World Health Organization Diagnostic Criteria." Diabetes Care. Vol. 22, (November 1999.): 1594-1595.

Osei K. "Metabolic Consequences of West African Diaspora: Lessons from the thrifty gene." Journal of Laboratory and Clinical Medicine. Vol. 33, no. 2. (February 1999.): 98-111.

Fernando C, Pesavento TE, Osei K, Henry ML. Ferguson RM. "Post transplantation diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.." Kidney International. Vol. 59, no. 2. (February 2001.): 732-739.

Amoah A.G., Osei K, Schuster D, Owusu SK. "Minimal Model Analyses of beta cell function, insulin secretion and glucose effectiveness in first degree relatives of Ghanaian patients with type 2 diabetes and healthy controls subjects.." Ethnicity and Disease. no. 11. (January 2001.): 201-210.

Amoah, Albert G, B; Schuster, Dara, P; Gaillard, Trudy; Osei, Kwame. "Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.." Ethnicity & disease. Vol. 12, no. 4. (January 2002.): S3-10.

Amoah, Albert G, B; Owusu, Samuel, K; Schuster, Dara, P; Osei, Kwame. "Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. Vol. 92, no. 5. (January 2002.): 377-84.

Amoah ABG, Owusu SK, Schuster DP. Gaillard T. Osei K. "Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians." Diabetologia. Vol. 7, no. 46. (January 2003.): 945-955.

Osei, Kwame; Schuster, Dara, P; Amoah, Albert G, B; Owusu, Samuel K. "Diabetes in Africa. Pathogenesis of type 1 and type 2 diabetes mellitus in sub-Saharan Africa: implications for transitional populations.." Journal of cardiovascular risk. Vol. 10, no. 2. (January 2003.): 85-96.

Osei, Kwame; Rhinesmith, Scott; Gaillard, Trudy; Schuster, Dara. "Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type." Metabolism: clinical and experimental. Vol. 52, no. 5. (January 2003.): 565-72.

Osei, Kwame; Rhinesmith, Scott; Gaillard, Trudy; Schuster, Dara. "Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?." The Journal of clinical endocrinology and metabolism. Vol. 88, no. 10. (January 2003.): 4596-601.

Osei, Kwame. "Global epidemic of type 2 diabetes: implications for developing countries.." Ethnicity & disease. Vol. 13, no. 2 Suppl 2. (January 2003.): S102-6.

Osei K, Schuster D, Amoah ABG, Owusu SK. "Pathogenetic mechanism of type 1 and type 2 diabetes in Sub- Saharan Africans: Implications for transitional countries." Journal of Cardiovascular Risk. Vol. 2, no. 10. (January 2003.): 85-96.

Osei, Kwame; Rhinesmith, Scott; Gaillard, Trudy; Schuster, Dara. "Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.." Metabolism: clinical and experimental. Vol. 53, no. 4. (January 2004.): 414-22.

Miller KS, Osei K. "Thyrotoxic hypokalemic periodic paralysis in an African American male with coexisting Graves Disease and Hashimoto thyroiditis." Endocrine Trends. no. 11. (January 2004.): 16-18.

Osei K, Scott R, Gaillard T, Kaplow J, Bullock M, Schuster D,. "Effects of Rosiglitazone on plasma adiponectin, insulin sensitivity and insulin secretion in African Americans with impaired glucose tolerance and type 2 diabetes." Metabolism. Vol. 53, no. 12. (December 2004.): 1552-1557.

Osei K, Scott R, Gaillard T, Schuster D. "Impaired insulin sensitivity, insulin secretion and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in prediabetic African Americans. Implications for primary diabetes prevention." Diabetes Care. Vol. 6, no. 27. (June 2004.): 1439-1446.

Osei, Kwame; Gaillard, Trudy; Kaplow, June; Bullock, Matthew; Schuster, Dara. "Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes.." Metabolism: clinical and experimental. Vol. 53, no. 12. (January 2004.): 1552-7.

Stakos, Dimitrios, A; Schuster, Dara, P; Sparks, Elizabeth, A; Wooley, Charles, F; Osei, Kwame; Boudoulas, Harisios. "Cardiovascular effects of type 1 diabetes mellitus in children.." Angiology. Vol. 56, no. 3. (January 2005.): 311-7.

Osei, Kwame; Gaillard, Trudy; Schuster, Dara. "Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.." Obesity research. Vol. 13, no. 1. (January 2005.): 179-85.

Osei, Kwame; Gaillard, Trudy; Cook, Charles; Kaplow, June; Bullock, Matthew; Schuster, Dara. "Discrepancies in the regulation of plasma adiponectin and TNF-alpha levels and adipose tissue gene expression in obese African Americans with glucose intolerance: a pilot study using rosiglitazone.." Ethnicity & disease. Vol. 15, no. 4. (January 2005.): 641-8.

Stakos DA, Schuster DP, Sparks EA, Wooley CF, Osei K, Boudoulas H.. "Cardiovascular effects of type 1 diabetes mellitus in children.." Angiology. Vol. 3, no. 56. (May 2005.): 311-317.

Stakos DA, Schuster DP, Sparks EA, Wooley CF, Osei K, Boudoulas H. "Long-term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomized study.." Heart. Vol. 5, no. 91. (May 2005.): 589-594.

Osei K, Scott R, Gaillard T, Schuster D,. "Plasma adiponectin in first degree relatives of African Americans parents with type 2 diabetes with normal glucose tolerance, impaired glucose tolerance and type 2 diabetes." Obesity Research. Vol. 1, no. 13. (January 2005.): 179-185.

Meis SB, Schsuter D, Gaillard T, Osei K.. "Metabolic Syndrome in Non-diabetic, Obese first degree relatives of African American patients with type 2 diabetes. African American Triglycerides-HDL- and insulin resistance paradox.." Ethnicity and Disease. Vol. 16, (September 2006.): 830-836.

Jain, Rajeev; Osei, Kwame; Kupfer, Stuart; Perez, Alfonso, T; Zhang, Jeff. "Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus.." Pharmacotherapy. Vol. 26, no. 10. (January 2006.): 1388-95.

Osei, Kwame; Gaillard, Trudy; Schuster, Dara. "Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.." Metabolism: clinical and experimental. Vol. 56, no. 1. (January 2007.): 24-9.

Osei K, Gaillard T, Schuster D.. "Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.." Metabolism. Vol. 1, no. 56. (January 2007.): 24-29.

Gaillard, Trudy, R; Sherman, W Michael; Devor, Steven, T; Kirby, Timothy, E; Osei, Kwame. "Importance of aerobic fitness in cardiovascular risks in sedentary overweight and obese African-American women.." Nursing research. Vol. 56, no. 6. (January 2007.): 407-15.

Schuster, Dara, P; Gaillard, Trudy; Osei, Kwame. "The cardiometabolic syndrome in persons of the African diaspora: challenges and opportunities.." Journal of the cardiometabolic syndrome. Vol. 2, no. 4. (January 2007.): 260-6.

Bonds, Denise, E; Kurashige, Ella Mae; Bergenstal, Richard; Brillon, David; Domanski, Michael; Felicetta, James, V; Fonseca, Vivian, A; Hall, Kathleen; Hramiak, Irene; Miller, Michael, E; Osei, Kwame; Simons-Morton, Denise, G; Simons-Morton, Denise G. "Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.." The American journal of cardiology. Vol. 99, no. 12A. (January 2007.): -.

Stakos, Dimitrios, A; Schuster, Dara, P; Sparks, Elizabeth, A; Meis, Sophia Boudoulas; Wooley, Charles, F; Osei, Kwame; Boudoulas, Harisios. "Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance.." European journal of endocrinology / European Federation of Endocrine Societies. Vol. 157, no. 1. (January 2007.): 63-8.

Gaillard T. Schuster D. Osei K.. "Independent role of blood pressure on cardiovascular risk factors in non-Diabetic, obese African American women. Implications for Metabolic Syndrome." Journal of the American Society of Hypertension (JASH). Vol. 3, no. 1. (October 2008.): 25-34.

Norris L, Collene A, Asp M, Hsu LF, Richardson JR, Li D, Bell D, Osei K, Jackson R, Belury M.. "Comparison of the dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes." american Journal of Clinical Nutrition. Vol. 90, no. 3. (September 2009.): 455-456.

Gaillard T, Schuster D, Osei K.. "Metabolic Syndrome in Black People of African Diaspora: The Paradox of current classification, definition and criteria.." Ethnicity and Disease. Vol. 19, (January 2009.): -.

Dungan KM, Osei K, Nagaraja HN, Schuster DS, Binkley P.. "Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during the implementation of hospital-wide initiatives.." Endocrine Practice. Vol. 16, no. 6. (November 2010.): 945-951.

Gaillard, T; Osei, K. "Insulin resistance and cardiovascular risk in African Diaspora." Current Cardiovascular Risk Reports. Vol. 4, no. 3. (January 2010.): 186-194.

Osei, K. "Metabolic Syndrome in blacks: Are the criteria right?." Current Diabetes Reports. Vol. 10, no. 3. (June 2010.): 199-208.

Osei K. "25 OH Vit D: Is it thee Universal Panacea for Metabolic Syndrome and Type 2 Diabetes?." Journal of Clinical Endocrinology and Metabolism. Vol. 9, no. 95. (September 2010.): -.

Dungan KM, Binkley P, Nagaraja HN, Schuster DS, Osei K. "Assessment of glycemic control and variability in patients hospitalized with congestive heart failure during the implementation of hospital-wide initiatives and effects on mortality.." Diabetes Metabolism Research & Reviews. (January 2010.): -.

Rivas, A., Landon M, Gaillard T, Schuster D, Osei K.. "The awareness of risk factors type 2 diabetes in women with current and former gestational diabetes mellitus : Implications for the future primary diabetes prevention.." Diabetes and Metabolic Syndrome: Clinical Research and REviews. Vol. 4, no. 2. (April 2010.): 89-94.

Gaillard T, Schuster D, Osei K.. "Differential impact of serum glucose, triglycerides and HDL-C on cardiovascular risk factor burden in non-diabetic African American Women.." Metabolism. Vol. 59, no. 8. (August 2010.): 1115-1123.

Dungan KM, Binkley P, Nagaraja HN, Schuster D, Osei K.. "The impact of glycemic control and glycemic variability on mortality in patients hospitalized with congestive heart failure.." Diabetes/Metabolism Research and Reviews. Vol. 1, no. 27(1). (January 2011.): 85-93.

Wang J, Osei K.. "Proinsulin maturation disorder is a contributor to the defect of subsequent conversion to insulin in beta cells.." Biochemical and Biophysical Research Communications. (January 2011.): -.

Gaillard T, Schuster D, Osei K. "Waist Circumference as a measure of cardiovascular risk factors in overweight and obese African American women." Journal of National Medical Association. (January 2011.): -.

Gaillard T. Parthasarathy S, Osei K.. "HDL Dysfunctionality (Paraoxonse) is worse in non-diabetic postmenopausal African American women.." Diabetes Care. Vol. 2, no. 34. (February 2011.): -.

Alhothani N, Dungan KM. Zappe J,, Schuster D, Osei K,. "The effect of glycemic variability on counter regulatory hormone responses to hypoglycemia in young children and adolescent with type 1 diabetes.." Diabetes Technology and Therapeutics. (January 2011.): -.

Gaillard T, Osei K.. "Ethnic differences in lipids/lipoproteins/apoliproteins and proinflammatory markers in non-diabetic African American and White postmenopausal women.." Diabetes; ed: Diabetes Care. (January 2011.): -.

Gaillard T, Go Michael, Sampath Parthasarathy, Osei K.. "Relationship between Carotid intima media thickness (CIMT) and proinflammatory markers in non-diabetic postmenopausal African American and White Women.." Diabetes. (January 2011.): -.

Dungan KM. Hall C, Schuster D, Osei K. "Comparison of three algorithms for basal insulin in transitioning stable post-cardiothoracic surgery patients from intravenous to subcutaneous insulin." Endocrine Practice. (May 2011.): -.

Wang I, Cehn Y, Yuan Q, Wei T, Xhang x, Osei K.. "Control of precursor maturation and disposal is an early regualive mechanism in the normal insulin production of pancreatic beta cells." PLoS One. Vol. 6, no. 4. (April 2011.): -.

 

Reference Works

January 1999 Schuster D, Gaillard T. Osei K.."Comparison of Minimal Model and Homeostasis Model Assessment Parameters in African Americans" .
January 2000 Schuster D. Gaillard T, Osei K.."Changes in OGTT associated with low dose metformin therapy in nondiabetic, at risk African Americans" . : 1361
January 2000 Burgun S, Gaillard TR, Habash D, Osei K,.."Macronutrient enrichment shows no differential effect on Postprandial energy expenditure in young women." .
January 2001 Schuster D, Gaillard T, Rogers J, Osei K.."Long -term effects of oral antidiabetic medications on Insulin action and beta cell function in African Americans with varying degrees of glucose tolerance" . : 149
January 2001 Osei K, Miller E, Everitt D, Ilgenfritz J, Porter L, Freed M."Rosiglitazone is effective and well tolerated in African Americans with type 2 diabetes." . : 51
January 2002 Osei K, Scott R, Gaillard T, Schuster D,."Primary prevention of type 2 diabetes in high risk, obese African Americans using Glipizide GITS. Metabolic effects of Chronic Glipizide(GITS)" .
January 2003 Gaillard T, Schuster D, Osei."t-degree relatives of African Americans with family history of type 2 diabetes" . : 2336:A539
January 2004 Gaillard T, Schuster D, Kaplow J, Bullock M, Osei K.."Relationship of adipocytokines to glucose homeostasis, insulin resistance, insulin secretion and body composition in health obese nondiabetic African American females" . : 1439, A346
January 2004 Osei K, Gaillard T, Schuster D.."Determinants of plasma adiponectin levels in first-degree relatives of African American parents with type 2 diabetes and varying degrees of glucose tolerance, insulin sensitivity and obesity indices." . : 1459, A351
January 2005 Schuster D, Gaillard T, Osei K.."Hepatic Steatosis may not be associated with Metabolic Syndrome in African Americans" . : 1423, A345
January 2005 Schuster D, Gaillard T, Osei K.."Hepatic Steatosis may not be associated with Metabolic Syndrome in African Americans." . : 1423, A345
January 2005 Osei K, Gaillard T, Schuster D.."Association of adiponectin with hepatic insulin extraction and insulin sensitivity in African Americans with varying degrees of glucose tolerance" . : P2602, A 627
January 2005 Meis S, Schuster D, Gaillard T, Osei K.."Prevalence and determinants of Metabolic Syndrome in African Americans with first-degree relatives of type 2 diabetes." . : 2511,A605
January 2006 Osei K, Gaillard T, Schuster D.."Impact of Obesity on Cardiovascular Risk Factors: A Study of Healthy Obese African American Women." . : P1731
January 2006 Osei K, Gaillard T, Cook C,Schuster D.."Rosiglitazone Increases Plasma Adiponectin (ADIPO) Levels but Not Adipose Tissue ADIPO Gene nor Skeletal Muscle ADIPO Receptor R1 and R2 Gene Expression in African Americans with Glucose Intolerance." . : P1346
January 2007 Gaillard T, Schuster D, Osei K.."Re-assessment of Adult Treatment Panel (ATP) III Guidelines in high risk African American women: The need for reclassification of thresholds for cardiovascular diseases" .
January 2007 Osei K, Gaillard T, Sherman W, Devor S, Kirby T.."Significance of aerobic fitness and cardiovascular risk in sedentary overweigh and obese African American Women." . : P354
January 2008 Gaillard T, Schuster D, Osei K.."Differential impact of serum glucose, triglycerides and HDL-C on prevalence of Metabolic Syndrome and its components in non-diabetic, obese African American women." .
January 2008 Gaillard T, Schuster D, Osei K.."Importance of aerobic fitness (Vo2max) in Metabolic Syndrome in sedentary overweight and obese African American women" .
January 2008 Gaillard T, Schuster D, Osei K."Independent role of blood pressure on metabolic syndrome and its components in non-diabetic African American women." . : 1817
January 2008 Gaillard T, Schuster D, Osei K."Independent impact of blood pressure on definition of metabolic syndrome in African American women" .
January 2009 Gaillard T, Schuster D, Osei K."Comparative Study of Clinical and Metabolic Parameters of MetabolicallyHealthy and Metabolically Unhealthy Overweight/Obese African American Women: Significance of Insulin Sensitive and Insulin Resistant Phenotypes" .

Presentations

"Modern treatment of type 2 diabetes." Cleveland, OH. (January 1994)

"Application of minimal model analysis in pancreas transplantation.." Presented at The Third International Conference on Minimal Model, Baton rouge, LA, US|USA. (January 1994)

"Ethnicity and insulin secretion and insulin action.." Presented at World Congress on Diabetes In the developing Countries, Accra, GH|GHA. (January 1995)

"Antidiabetic agents in the prevention of diabetes in high risk African Americans." Bethesda, MD, US|USA. (January 1995)

"Overview of type 2 diabetes." Chillicothe, OH. (January 1996)

"African American Diabetes Initiative." Washington DC, MA, US|USA. (January 1996)

"New strategies in the treatment of type 2 diabetes; The Dawn of a New Era." Presented at Medical Grand Rounds, Columbus, OH. (January 1997)

"New Strategies in the management of type 2 diabetes." Columbus, OH. (January 1997)

"Insulin, insulin resistance and Cardiovascular diseases." Presented at Annual Scientific Meeting of American College of Cardiology, Aneheim, CA, US|USA. (March 1997)

"Update: Diabetes in the new millennium." Columbus, OH. (January 1998)

"Insulin Therapy in Diabetes." Columbus, OH. (January 1999)

"Overcoming Insulin Resistance." Toledo, OH. (January 2000)

"Management of type 1 diabetes: The role of islet cell transplantation and new technologies." Presented at Medical Grand Rounds, Columbus, OH, US|USA. (January 2000)

"New oral antidiabetic medications: use of combination therapy." Columbus, OH. (January 2001)

"Ragaglitazar improves lipid and glycemic control in hypertriglyceridemic type 2 diabetes." Budapest, HU|HUN. (January 2002)

"Ragaglitazar improves lipid and glycemic control in hypertriglyceridemic type 2 diabetes." Budapest, HU|HUN. (January 2002)

"Risk factors for cardiovascular diseases in diabetes; beyond glucose." Columbus, OH. (January 2002)

"Racial differences in the pathophysiology of type 2 diabetes." New Orleans, LO. (January 2002)

"Insulin therapies and insulin delivery devices." Memphis, TN. (January 2002)

"Global epidemic of diabetes: importance of race and ethnicity." Miami, FL, US|USA. (January 2002)

"Ethnicity and Glucose Regulation." Louisville, KY. (January 2002)

"Cardiovascular diseases in diabetes: beyond glucose and lipids." Honolulu, HI, US|USA. (January 2002)

"Type 2 diabetes: importance of beta cell preservation." Columbus, OH. (January 2003)

"Rationale management of type 2 diabetes: the effective use of oral and antidiabetic medications." Columbus,, OH. (January 2003)

"Pathogenesis of type 2 diabetes: importance of beta cell dysfunction and insulin resistance." Columbus, OH. (January 2003)

"Pathogenesis of type 2 diabetes: importance of beta cell dysfunction and insulin resistance." Presented at Joslin Diabetes Symposium, Washington, DC, MD. (January 2003)

"Glucoregulation and obesity: How important is Ethnicity and Race." Fort Lauderdale, FL. (January 2003)

"Convergence of Etiology and Management of Diabetes." Presented at Evolution of Diabetes, Columbus, OH. (January 2003)

"Century of evolution of Diabetes: Convergence of etiology and management of type 1 and type 2 diabetes." Presented at Plenary session, Philadelphia, PA. (January 2003)

"Glucoregulation, obesity and andipocytokines: role of ethnicity." Nashville, TN. (November 2003)

"Heart Failure." Presented at Diabetes and Obesity, Columbus, OH. (January 2004)

"Determinants of adiponectin in high risk African Americans with normal glucose tolerance, impaired glucose tolerance and type 2 diabetes." Orlando, FL, US|USA. (January 2004)

"Cardiovascular Risks Factors: Transatlantic Studies." Presented at American Black Cardiologist Association, New Orleans, LA, US|USA. (January 2004)

"Changes, Phases of Diabetes and Obesity: Future of Destiny." Columbus, OH. (January 2004)

"Physician resistance to insulin therapy." . (August 2004)

"Insulin Resistance and obesity derived peptides." . (August 2004)

"Heart Failure, obesity and diabetes." Columbus, OH. (August 2004)

"Type 1 and 2 diabetes: convergence of Etiology and Management." Presented at Endocrine Update, Columbus, OH. (March 2004)

"Race and Ethnicity and Cardiovascular Risk Factors. Where do we go from here?." Presented at NIH RCMI Conference, Baltimore, MD, US|USA. (January 2005)

"Obesity and Diabetes in African American Men." . (January 2005)

"Black Women's Health." Columbus, OH. (January 2005)

"Predictors of type 2 diabetes in high risk African Americans: implications for primary diabetes prevention." Presented at Lester Henry Lecture, . (May 2005)

"Obesity and Metabolic Syndrome: Importance of Ethnicity and Race." Presented at ISHIB Conference, . (January 2008)

"Metabolic Syndrome: Importance of Ethnicity and Race." Presented at ISHIB Conference, . (January 2008)

"Health Care Disparities: Future Directions for Young Investigators:." Presented at NIH NMRI Midwest Conference, US|USA. (January 2008)

"Significance of HDL-TRIG in the definition of insulin resistance and metabolic syndrome in African Americans." Rome, Italy. (September 2008)

"Pre-treatment with exenatide in islet cell transplantation donors and recipients improves graft function in the non-human primate model.." Presented at ADA, New Orleans, New Orleans. (January 2009)

"Gender differences in glucose tolerance and andiponectin levels in native Ghanians with family history of diabetes." New Orleans. (January 2009)